Exact Mass: 481.2035

Exact Mass Matches: 481.2035

Found 500 metabolites which its exact mass value is equals to given mass value 481.2035, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Acebilustat

4-[[5-[[4-[4-(1,3-Oxazol-2-yl)phenoxy]phenyl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]benzoic acid

C29H27N3O4 (481.2001)

Stallimycin

1H-Pyrrole-2-carboxamide,N-[5-[[(3-amino-3-iminopropyl)amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]-4-[[[4-(formylamino)-1-methyl-1H-pyrrol-2-yl]carbonyl]amino]-1-methyl-

C22H27N9O4 (481.2186)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D004214 - Distamycins D000890 - Anti-Infective Agents > D000998 - Antiviral Agents

gamma-Glutamyl-N'-(2-hydroxyphenyl)hydrazide

4-Amino-5-{4-hydroxy-3-[4-(2-hydroxyphenyl)tetraazan-1-yl]phenyl}-N-(2-hydroxyphenyl)-5-oxopentanehydrazonate

C23H27N7O5 (481.2074)

1,3-Dithiane-2-propanamine, N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-2-(2-naphthalenyl)-

[2-(3,4-dimethoxyphenyl)ethyl](methyl){3-[2-(naphthalen-2-yl)-1,3-dithian-2-yl]propyl}amine

C28H35NO2S2 (481.2109)

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

C21H31N5O6S (481.1995)

Met Cys Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]hexanamido]-3-hydroxybutanoic acid

C18H35N5O6S2 (481.2029)

Met Cys Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]hexanoic acid

C18H35N5O6S2 (481.2029)

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]propanoic acid

C21H31N5O6S (481.1995)

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-phenylpropanamido]-3-carbamoylpropanamido]butanedioic acid

C20H27N5O9 (481.1809)

Ser Phe Gln Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-phenylpropanamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C21H31N5O8 (481.2173)

Ser Phe Thr Gln

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-phenylpropanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C21H31N5O8 (481.2173)

C31H31NO4 (481.2253)

3-Ethyl-5-methyl-4-(2-chlorophenyl)-2-(2,2-diethoxy-ethoxymethyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

C24H32ClNO7 (481.1867)

Cerivastatin sodium

C26H33FNNaO5 (481.224)

D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites Cerivastatin sodium is a synthetic lipid-lowering agent and a highly potent, well-tolerated and orally active HMG-CoA reductase inhibitor, with a Ki of 1.3 nM/L. Cerivastatin sodium reduces low-density lipoprotein cholesterol levels. Cerivastatin sodium also inhibits proliferation and invasiveness of MDA-MB-231 cells, mainly by RhoA inhibition, and has anti-cancer effect[1][2].

Acebilustat

C29H27N3O4 (481.2001)

COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent > C574 - Immunosuppressant Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

diethyl 2,6-bis((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

C23H32ClN3O6 (481.198)

1,3-Dithiane-2-propanamine, N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-2-(2-naphthalenyl)-

C28H35NO2S2 (481.2109)

1-[2-(3-Biphenyl)-4-methylvaleryl)]amino-3-(2-pyridylsulfonyl)amino-2-propanone

C26H31N3O4S (481.2035)

[3-(Hydroxymethyl)-1-{[4-({1-[5-(4-methoxyphenyl)-1,3,4-oxadiazole-2-carbonyl]azetidin-3-yl}oxy)phenyl]methyl}azetidin-3-yl]methanol

C25H29N4O6+ (481.2087)

Cbz-DL-Val-DL-Ala-DL-Asp-AcF

n-(2-{2-[(4-hydroxy-1-methyl-2-oxoquinolin-3-yl)(4-hydroxyphenyl)methyl]-1h-indol-3-yl}ethyl)ethanimidic acid

C29H27N3O4 (481.2001)

2,21-dimethyl (1s,12r,19r,21s,24s)-24-cyano-21-hydroxy-5,7-dioxa-2,15-diazaheptacyclo[17.2.2.1¹²,¹⁵.0¹,¹².0³,¹¹.0⁴,⁸.0¹⁹,²⁴]tetracosa-3(11),4(8),9-triene-2,21-dicarboxylate

C25H27N3O7 (481.1849)

(1r,13s,16r,22s,25s)-16-hydroxy-25-(hydroxymethyl)-7,7,26,26-tetramethyl-6,24-dioxa-12,14,20-triazaheptacyclo[11.10.3.0¹,¹³.0²,¹¹.0⁵,¹⁰.0¹⁴,²².0¹⁶,²⁰]hexacosa-2(11),3,5(10),8-tetraene-15,21-dione

(1r,13s,16r,22s,25s)-16-hydroxy-25-(hydroxymethyl)-7,7,26,26-tetramethyl-6,24-dioxa-12,14,20-triazaheptacyclo[11.10.3.0¹,¹³.0²,¹¹.0⁵,¹⁰.0¹⁴,²².0¹⁶,²⁰]hexacosa-2(11),3,5(10),8-tetraene-15,21-dione

C26H31N3O6 (481.2213)